Siccardi, Marco ORCID: 0000-0002-3539-7867, Schapiro, Jonathan, Di Perri, Giovanni and Back, David J
(2020)
The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (9).
pp. 2381-2383.
Text
dkaa272 (1).pdf - Published version Download (125kB) | Preview |
Abstract
The development of therapeutic agents against SARS-CoV-2/COVID-19 faces numerous barriers and a multidisciplinary approach to evaluating drug efficacy and toxicity is essential. Experimental and preclinical data should be integrated into a comprehensive analysis, where drug potency, the timing of therapy initiation, drug combinations, variability in systemic and local drug exposure and short- and long-term toxicities represent fundamental factors for the rational identification of candidates and prioritization of clinical investigations. Although the identification of SARS-CoV-2 therapeutics is a priority, rigorous and transparent methodologies are crucial to ensure that accelerated research programmes result in high-quality and reproducible findings.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Animals, Humans, Pneumonia, Viral, Coronavirus Infections, Antibodies, Viral, Antiviral Agents, Drug Discovery, Pandemics, Betacoronavirus, COVID-19, SARS-CoV-2 |
Depositing User: | Symplectic Admin |
Date Deposited: | 06 Jul 2020 09:59 |
Last Modified: | 18 Jan 2023 23:47 |
DOI: | 10.1093/jac/dkaa272 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3092639 |